Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog
RATNA RAY
Proceedings of The National Academy of Sciences, 2009
View PDFchevron_right
Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus
Jian-chang Liu
Journal of gastroenterology and hepatology, 2012
View PDFchevron_right
Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma
Dan Yu
Cancer letters, 2015
View PDFchevron_right
Building a bridge between obesity, inflammation and liver carcinogenesis
Jessica zucman-rossi
Journal of Hepatology, 2010
View PDFchevron_right
CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Antonia Castilho
Cell Stem Cell, 2011
View PDFchevron_right
Alcohol, TLR4-TGF-β antagonism, and liver cancer
Keigo Machida
Hepatology International, 2013
View PDFchevron_right
NANOG metabolically reprograms tumor-initiating stem-like cells in oxidative phosphorylation and fatty acid metabolism
uthaya kumar
2015
View PDFchevron_right
Significance of Toll-like Receptor 4 ( TLR4 )& Liver Fatty Acid-binding Protein (L-FABP) Expression in Hepatocellular Carcinoma An Immunohistochemical Study
Reda El badawy
2020
View PDFchevron_right
Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease
Antonio Picardi
Modern Pathology, 2012
View PDFchevron_right
Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice
Scott Esckilsen
Journal of Cellular Biochemistry, 2015
View PDFchevron_right
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Ramón Bataller
Cancer Cell, 2012
View PDFchevron_right
PS-046-Suppression of complex protumorigenic phenotypes in chronic injury-associated hepatocarcinogenesis is dependent on IL-6/STAT3 signaling
Rinat Abramovitch
Journal of Hepatology, 2019
View PDFchevron_right
Mir-26a-IL-6-IL-17 Axis Regulates the Development of Non-alcoholic Fatty Liver Disease in a Murine Model
Jinke Li
Clinical and experimental immunology, 2016
View PDFchevron_right
Modulation of Non-Alcoholic Steatohepatitis by Pattern Recognition Receptors in Mice: The Role of Toll-Like Receptors 2 and 4
Pranoti Mandrekar
Alcoholism: Clinical & Experimental Research, 2005
View PDFchevron_right
Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes
Ratna ray
Journal of virology, 2015
View PDFchevron_right
Interleukin-17 programs liver progenitor cell transformation into cancer stem cells through mir-122 downregulation with increased risk of primary liver cancer initiation
Arthur Brouillet
International Journal of Biological Sciences, 2022
View PDFchevron_right
Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver
Charles Nicaise, Christophe Moreno
Hepatology, 2006
View PDFchevron_right
Hepatoprotective versus Oncogenic Functions of STAT3 in Liver Tumorigenesis
Hua Wang
The American Journal of Pathology, 2011
View PDFchevron_right
Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival
Sujoy Lahiri
Nature communications, 2017
View PDFchevron_right
Mechanisms by which TLR4 and endotoxin promote hepatocellular carcinoma require further investigation
Ali A Mencin
Hepatology, 2011
View PDFchevron_right
Key features of the environment promoting liver cancer in the absence of cirrhosis
Sameh AbouBeih
View PDFchevron_right
Silencing of TLR4 Decreases Liver Tumor Burden in a Murine Model of Colorectal Metastasis and Hepatic Steatosis
Ian Nicoud
Annals of Surgical Oncology, 2009
View PDFchevron_right
Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice
George Yeoh
Journal of Experimental Medicine, 2000
View PDFchevron_right
Nod2 protects mice from inflammation and obesity-dependent liver cancer
Bill Trimoski
Scientific Reports
View PDFchevron_right
The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases
Pedro Pimentel-nunes
Hepatology International, 2010
View PDFchevron_right
Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response
Claire Piquet-pellorce
Cancers, 2020
View PDFchevron_right
Hepatitis C Virus-Induced Cancer Stem Cell-Like Signatures in Cell Culture and Murine Tumor Xenografts
shahid umar
Journal of Virology, 2011
View PDFchevron_right
A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis
Daniel Heise
International Journal of Molecular Sciences, 2019
View PDFchevron_right
P0245 : The IL-6/SIL6R and STAT3 axis is crucial for hepatoprotection and suppression of liver cancer in female mice with chronic liver injury
Rinat Abramovitch
Journal of Hepatology, 2015
View PDFchevron_right
Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms
Jean-pierre Couty
Hormone Molecular Biology and Clinical Investigation, 2020
View PDFchevron_right
Correlation between cancer stem cells, inflammation and malignant transformation in a DEN-induced model of hepatic carcinogenesis
Sheau-Fang Yang
2020
View PDFchevron_right
Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro
Chih-cheng Hsiao
Pediatric Blood & Cancer, 2013
View PDFchevron_right